Skip to main content

Table 3 Univariate and multivariate analyses of clinical, surgery-related prognostic factors for postoperative survival

From: Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study

Factor

Category

Cause-specific survival

Recurrence-free survival

Univariate

Multivariate

Univariate

Multivariate

p value

p value

HRa

(95% CIb)

p value

p value

HR

(95% CIb)

Age

< 70 (vs. ≥70)

0.853

   

0.129

   

Sex

Male (vs. Female)

0.796

   

0.398

   

Body mass index

< 20 (vs. ≥20)

0.378

   

0.328

   

Tumor location

Utc (vs. Mtd or Lte)

0.868

   

0.791

   

Histology

non-SCCf (vs. SCC)

0.113

   

0.017*

0.088

1.760

(0.919–3.369)

Neoadjuvant chemotherapy

Present (vs. Absent)

0.689

   

0.138

   

Adjuvant chemotherapy

Present (vs. Absent)

0.007*

0.325

1.731

(0.581–5.155)

0.120

   

cT factor

cT2–3 (vs. T1)

0.054

0.871

0.926

(0.366–2.343)

0.004*

0.205

1.558

(0.784–3.094)

Clinical mediastinal lymph node metastasis

Present (vs. Absent)

0.023*

0.811

0.908

(0.413–1.998)

0.005*

0.699

1.131

(0.607–2.108)

Clinical abdominal lymph node metastasis

Present (vs. Absent)

0.000*

0.000*

3.917

(1.860–8.250)

0.000*

0.007*

2.162

(1.237–3.781)

Thoracic approach

VATSg (vs. OTh)

0.000*

0.017*

0.387

(0.178–0.842)

0.001*

0.021*

0.514

(0.292–0.902)

Abdominal approach

HALSi (vs. OLj)

0.170

   

0.100

   

Reconstruction route

mediastinal or antethoracic (vs. Retrosternal)

0.105

   

0.398

   
  1. aHR hazard ratio, bCI confidence interval, cUt Upper thoracic, dMt Middle thoracic, eLt Lower thoracic, fSCC squamous cell carcinoma, gVATS Video assisted thoracic surgery, hOT Open thoracotomy, iHALS Hand assisted laparoscopic surgery, jOL Open Laparotomy. *: p < 0.05